Clinical Trial Update: Placebo-Controlled Trial With GlyTI-M Among Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2]

View source ↗

Summary

A Phase 2, placebo-controlled trial evaluating GlyTI-M in children with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• GlyTI-M

Snippet

Sponsor: Mackay Memorial Hospital | Conditions: ADHD | Phase 2 | Status: COMPLETED